ATE485398T1 - Verfahren zu der identifizierung von genetischen markern für sekundärtumore und mittel zur identifizierung, markierung und zur gezielten behandlung von sekundären tumoren - Google Patents

Verfahren zu der identifizierung von genetischen markern für sekundärtumore und mittel zur identifizierung, markierung und zur gezielten behandlung von sekundären tumoren

Info

Publication number
ATE485398T1
ATE485398T1 AT06090096T AT06090096T ATE485398T1 AT E485398 T1 ATE485398 T1 AT E485398T1 AT 06090096 T AT06090096 T AT 06090096T AT 06090096 T AT06090096 T AT 06090096T AT E485398 T1 ATE485398 T1 AT E485398T1
Authority
AT
Austria
Prior art keywords
identifying
transcription factors
tumor
liver
organ
Prior art date
Application number
AT06090096T
Other languages
English (en)
Inventor
Juergen Borlak
Frank Lehner
Juergen Klempnauer
Original Assignee
Fraunhofer Ges Forschung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Ges Forschung filed Critical Fraunhofer Ges Forschung
Application granted granted Critical
Publication of ATE485398T1 publication Critical patent/ATE485398T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT06090096T 2006-06-02 2006-06-02 Verfahren zu der identifizierung von genetischen markern für sekundärtumore und mittel zur identifizierung, markierung und zur gezielten behandlung von sekundären tumoren ATE485398T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06090096A EP1862556B1 (de) 2006-06-02 2006-06-02 Verfahren zu der Identifizierung von genetischen Markern für Sekundärtumore und Mittel zur Identifizierung, Markierung und zur gezielten Behandlung von sekundären Tumoren

Publications (1)

Publication Number Publication Date
ATE485398T1 true ATE485398T1 (de) 2010-11-15

Family

ID=37076092

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06090096T ATE485398T1 (de) 2006-06-02 2006-06-02 Verfahren zu der identifizierung von genetischen markern für sekundärtumore und mittel zur identifizierung, markierung und zur gezielten behandlung von sekundären tumoren

Country Status (5)

Country Link
US (1) US20100069255A1 (de)
EP (1) EP1862556B1 (de)
AT (1) ATE485398T1 (de)
DE (1) DE602006017664D1 (de)
WO (1) WO2007141046A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8280134B2 (en) * 2008-09-22 2012-10-02 Cambridge Research & Instrumentation, Inc. Multi-spectral imaging including at least one common stain
US11926817B2 (en) 2019-08-09 2024-03-12 Nutcracker Therapeutics, Inc. Microfluidic apparatus and methods of use thereof
CN111596069B (zh) * 2020-06-03 2021-08-06 四川大学华西第二医院 Hsp10在pop早期预警、诊断、预后评估中的应用和产品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625169B2 (en) * 1987-03-23 1992-07-02 Imperial Chemical Industries Plc Molecular markers
WO2002088332A1 (fr) * 2001-04-24 2002-11-07 Hokkaido Technology Licensing Office Co.,Ltd. Colonie riche en petites cellules hepatiques, procede d'obtention de cette colonie, procede d'induction de la maturation de cette colonie dans un tissu hepatique et procede d'estimation de l'effet d'un medicament faisant appel a cette colonie riche en petites cellules hepatiques mature
ZA200204907B (en) * 2001-06-26 2003-03-03 Univ Nat Taiwan Collapsin Response Mediator Protein-1.
WO2004063355A2 (en) * 2003-01-10 2004-07-29 Protein Design Labs, Inc. Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer

Also Published As

Publication number Publication date
US20100069255A1 (en) 2010-03-18
DE602006017664D1 (de) 2010-12-02
EP1862556A1 (de) 2007-12-05
WO2007141046A2 (en) 2007-12-13
EP1862556B1 (de) 2010-10-20
WO2007141046B1 (en) 2008-05-22
WO2007141046A3 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
Zahran et al. Salivary micro RNA s in oral cancer
Feber et al. UroMark—a urinary biomarker assay for the detection of bladder cancer
Vriens et al. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer
de la Rica et al. TET-dependent regulation of retrotransposable elements in mouse embryonic stem cells
Xi et al. Nanopore-based selective discrimination of microRNAs with single-nucleotide difference using locked nucleic acid-modified probes
Wijnhoven et al. MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma
Delpu et al. DNA methylation and cancer diagnosis
Zhang et al. Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland
ES2568900T3 (es) Ensayo para la metilación en el gen para la GST-Pi
Bennett et al. DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma
CY1117260T1 (el) Δοκιμασια συλληψης -επανω σε- αποκομμα διαμορφωσης χρωμοσωματων (chromosome conformation capture-on-chip) (4c)
WO2009118204A3 (en) Medicament, compositions, and substances for treating and identifying adenocarcinoma of the lung
JP2019528704A5 (de)
Xavier et al. Epigenetic repression of HOXB cluster in oral cancer cell lines
DE60043182D1 (de) Methode zur dns-sequenzierung
Ortiz et al. Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma
ATE555219T1 (de) Korrekturlese-primerverlängerung
Samadani et al. CDX1/2 and KLF5 expression and epigenetic modulation of sonic hedgehog signaling in gastric adenocarcinoma
JP2016533708A5 (de)
ATE485398T1 (de) Verfahren zu der identifizierung von genetischen markern für sekundärtumore und mittel zur identifizierung, markierung und zur gezielten behandlung von sekundären tumoren
Dedeoğlu High-throughput approaches for microRNA expression analysis
Moreira et al. MiRNA expression profile for the human gastric antrum region using ultra-deep sequencing
CN105378107A (zh) 多重甲基化-特异性扩增系统和方法
Schulz et al. Epigenetics of urothelial carcinoma
Mishra et al. Epigenetics of solid cancer stem cells

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties